The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
The next generation of therapeutics for chronic kidney disease
Open accessAbstract
Chronic kidney disease (CKD) represents a leading cause of death in the United States. There is no cure for this disease, with current treatment strategies relying on blood pressure control through blockade of the renin–angiotensin system. Such approaches only delay the development of end-stage kidney disease and can be associated with serious side effects. Recent identification of several novel mechanisms contributing to CKD development — including vascular changes, loss of podocytes and renal epithelial cells, matrix deposition, inflammation and metabolic dysregulation — has revealed new potential therapeutic approaches for CKD. This Review assesses emerging strategies and agents for CKD treatment, highlighting the associated challenges in their clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,527
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,908
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,517
Cell biology of the glomerular podocyte
Pavenstädt, H., Kriz, W., & Kretzler, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00020.2002 · Cited by 1,499
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
Tangri, N. (2011) · JAMA · doi:10.1001/jama.2011.451 · Cited by 1,348
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319
Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,313
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
O'Shea, J. J., & Plenge, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.014 · Cited by 1,138
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Chapter 1: Definition and classification of CKD
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.64 · Cited by 1,110
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Self-citationThe Central Role of Endothelial Dysfunction in Cardiorenal Syndrome
Zhang, J., Bottiglieri, T., & McCullough, P. A. (2017) · Cardiorenal Medicine · doi:10.1159/000452283 · Cited by 1,080
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.39 · Cited by 1,041
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Coresh, J., Turin, T. C., Matsushita, K., Sang, Y., Ballew, S. H., Appel, L. J., Arima, H., Chadban, S. J., Cirillo, M., Djurdjev, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.6634 · Cited by 988
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., Cohen, C. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30487 · Cited by 976
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Foley, R. N., Murray, A. M., Li, S., Herzog, C. A., McBean, A. M., Eggers, P. W., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004030203 · Cited by 972
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Molecular mechanisms of diabetic kidney disease
Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 909
Self-citationThe Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Davis, C. F., Ricketts, C. J., Wang, M., Yang, L., Cherniack, A. D., Shen, H., Buhay, C., Kang, H., Kim, S. C., Fahey, C. C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.014 · Cited by 842
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1685 · Cited by 823
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310345 · Cited by 784
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778
Matsushima, K., Larsen, C. G., DuBois, G. C., & Oppenheim, J. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1485 · Cited by 756
Wharram, B. L., Goyal, M., Wiggins, J. E., Sanden, S. K., Hussain, S., Filipiak, W. E., Saunders, T. L., Dysko, R. C., Kohno, K., Holzman, L. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010055 · Cited by 737
Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
Durant, L., Watford, W. T., Ramos, H. L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H., Sun, H.-W., Kanno, Y., Powrie, F., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.003 · Cited by 726
Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
Hou, F. F., Zhang, X., Zhang, G. H., Xie, D., Chen, P. Y., Zhang, W. R., Jiang, J. P., Liang, M., Wang, G. B., Liu, Z. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053107 · Cited by 710
Tyson, C. C., & Coffman, T. M. (2017) · Nephron · doi:10.1159/000455130 · Cited by 710
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686
Therapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Nishitoh, H., Saitoh, M., Mochida, Y., Takeda, K., Nakano, H., Rothe, M., Miyazono, K., & Ichijo, H. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80283-x · Cited by 646
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Self-citationMethylation determines fibroblast activation and fibrogenesis in the kidney
Bechtel, W., McGoohan, S., Zeisberg, E. M., Müller, G. A., Kalbacher, H., Salant, D. J., Müller, C. A., Kalluri, R., & Zeisberg, M. (2010) · Nature Medicine · doi:10.1038/nm.2135 · Cited by 639
Cellular and molecular mechanisms in kidney fibrosis
Duffield, J. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72267 · Cited by 629
Levey, A. S., Inker, L. A., Matsushita, K., Greene, T., Willis, K., Lewis, E., de Zeeuw, D., Cheung, A. K., & Coresh, J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.030 · Cited by 620
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
Vlassara, H., Brownlee, M., Manogue, K. R., Dinarello, C. A., & Pasagian, A. (1988) · Science · doi:10.1126/science.3259727 · Cited by 597
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Tartaglia, L. A., Pennica, D., & Goeddel, D. V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46661-0 · Cited by 562
The missing link: A single unifying mechanism for diabetic complications
Nishikawa, T., Edelstein, D., & Brownlee, M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07705.x · Cited by 510
Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., & Shibuya, M. (2001) · Blood · doi:10.1182/blood.v97.3.785 · Cited by 500
Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection
Crawford, A., Angelosanto, J. M., Kao, C., Doering, T. A., Odorizzi, P. M., Barnett, B. E., & Wherry, E. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.005 · Cited by 496
Nath, K. A., Hostetter, M. K., & Hostetter, T. H. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112020 · Cited by 495
Avosentan for Overt Diabetic Nephropathy
Mann, J. F. E., Green, D., Jamerson, K., Ruilope, L. M., Kuranoff, S. J., Littke, T., & Viberti, G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060593 · Cited by 492
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Niewczas, M. A., Gohda, T., Skupien, J., Smiles, A. M., Walker, W. H., Rosetti, F., Cullere, X., Eckfeldt, J. H., Doria, A., Mayadas, T. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060627 · Cited by 485
Vallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Xie, X., Liu, Y., Perkovic, V., Li, X., Ninomiya, T., Hou, W., Zhao, N., Liu, L., Lv, J., Zhang, H., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.10.011 · Cited by 479
Sabbisetti, V. S., Waikar, S. S., Antoine, D. J., Smiles, A., Wang, C., Ravisankar, A., Ito, K., Sharma, S., Ramadesikan, S., Lee, M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070758 · Cited by 465
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function
Dugan, L. L., You, Y.-H., Ali, S. S., Diamond-Stanic, M., Miyamoto, S., DeCleves, A.-E., Andreyev, A., Quach, T., Ly, S., Shekhtman, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66218 · Cited by 456
Collins, A. J., Foley, R. N., Gilbertson, D. T., & Chen, S.-C. (2015) · Kidney International Supplements · doi:10.1038/kisup.2015.2 · Cited by 452
Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes
Nieuwdorp, M., Mooij, H. L., Kroon, J., Atasever, B., Spaan, J. A. E., Ince, C., Holleman, F., Diamant, M., Heine, R. J., Hoekstra, J. B. L., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1619 · Cited by 442
The Notch pathway in podocytes plays a role in the development of glomerular disease
Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., & Susztak, K. (2008) · Nature Medicine · doi:10.1038/nm1731 · Cited by 427
Self-citationTransgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
Kopp, J. B., Factor, V. M., Mozes, M., Nagy, P., Sanderson, N., Böttinger, E. P., Klotman, P. E., & Thorgeirsson, S. S. (1996) · PubMed · Cited by 422
Licht, C., Greenbaum, L. A., Muus, P., Babu, S., Bedrosian, C. L., Cohen, D. J., Delmas, Y., Douglas, K., Furman, R. R., Gaber, O. A., et al. (2015) · Kidney International · doi:10.1038/ki.2014.423 · Cited by 420
Gomez, I. G., MacKenna, D. A., Johnson, B. G., Kaimal, V., Roach, A. M., Ren, S., Nakagawa, N., Xin, C., Newitt, R., Pandya, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75852 · Cited by 413
Abatacept in B7-1–Positive Proteinuric Kidney Disease
Yu, C.-C., Fornoni, A., Weins, A., Hakroush, S., Maiguel, D., Sageshima, J., Chen, L., Ciancio, G., Faridi, M. H., Behr, D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304572 · Cited by 384
Mogensen, C. E. (1976) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517609055274 · Cited by 375
The cell biology of renal filtration
Scott, R. P., & Quaggin, S. E. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201410017 · Cited by 372
on behalf of the FIELD Study investigators, Davis, T. M. E., Ting, R., Best, J. D., Donoghoe, M. W., Drury, P. L., Sullivan, D. R., Jenkins, A. J., O’Connell, R. L., Whiting, M. J., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1951-1 · Cited by 371
Schoolwerth, A. C., Sica, D. A., Ballermann, B. J., & Wilcox, C. S. (2001) · Circulation · doi:10.1161/hc4101.096153 · Cited by 363
Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis
Humphreys, B. D., Xu, F., Sabbisetti, V., Grgic, I., Naini, S. M., Wang, N., Chen, G., Xiao, S., Patel, D., Henderson, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci45361 · Cited by 361
Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Nichols, B., Jog, P., Lee, J. H., Blackler, D., Wilmot, M., D'Agati, V., Markowitz, G., Kopp, J. B., Alper, S. L., Pollak, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.270 · Cited by 355
Bielesz, B., Sirin, Y., Si, H., Niranjan, T., Gruenwald, A., Ahn, S., Kato, H., Pullman, J., Gessler, M., Haase, V. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43025 · Cited by 345
Self-citationThe Number, Quality, and Coverage of Randomized Controlled Trials in Nephrology
Strippoli, G. F. M., Craig, J. C., & Schena, F. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000100125.21491.46 · Cited by 343
Wada, T., Furuichi, K., Sakai, N., Iwata, Y., Yoshimoto, K., Shimizu, M., Takeda, S.-I., Takasawa, K., Yoshimura, M., Kida, H., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00311.x · Cited by 341
Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor
Tartaglia, L. A., Rothe, M., Hu, Y.-F., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90222-c · Cited by 339
Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336
Changes in Diabetes-Related Complications in the United States
(2014) · New England Journal of Medicine · doi:10.1056/nejmc1406009 · Cited by 326
Angiopoietin-Like Proteins: A Comprehensive Look
Santulli, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00004 · Cited by 320
Pirfenidone for Diabetic Nephropathy
Sharma, K., Ix, J. H., Mathew, A. V., Cho, M., Pflueger, A., Dunn, S. R., Francos, B., Sharma, S., Falkner, B., McGowan, T. A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101049 · Cited by 319
Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
Karimi-Shah, B. A., & Chowdhury, B. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500526 · Cited by 316
Endothelin and endothelin antagonists in chronic kidney disease
Kohan, D. E., & Barton, M. (2014) · Kidney International · doi:10.1038/ki.2014.143 · Cited by 307
Wang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S., Chua, S., & Levi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2328 · Cited by 303
Collecting Duct Principal Cell Transport Processes and Their Regulation
Pearce, D., Soundararajan, R., Trimpert, C., Kashlan, O. B., Deen, P. M. T., & Kohan, D. E. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05760513 · Cited by 303
Goicoechea, M., Garcia de Vinuesa, S., Verdalles, U., Verde, E., Macias, N., Santos, A., Pérez de Jose, A., Cedeño, S., Linares, T., & Luño, J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.11.016 · Cited by 302
de Zeeuw, D., Coll, B., Andress, D., Brennan, J. J., Tang, H., Houser, M., Correa-Rotter, R., Kohan, D., Lambers Heerspink, H. J., Makino, H., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080830 · Cited by 302
Eijkelkamp, W. B. A., Zhang, Z., Remuzzi, G., Parving, H.-H., Cooper, M. E., Keane, W. F., Shahinfar, S., Gleim, G. W., Weir, M. R., Brenner, B. M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050445 · Cited by 302
Cloning of Vascular Adhesion Protein 1 Reveals a Novel Multifunctional Adhesion Molecule
Smith, D. J., Salmi, M., Bono, P., Hellman, J., Leu, T., & Jalkanen, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.17 · Cited by 301
Levey, A. S., Cattran, D., Friedman, A., Miller, W. G., Sedor, J., Tuttle, K., Kasiske, B., & Hostetter, T. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.029 · Cited by 298
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 296
Daehn, I., Casalena, G., Zhang, T., Shi, S., Fenninger, F., Barasch, N., Yu, L., D’Agati, V., Schlondorff, D., Kriz, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71195 · Cited by 294
Molecules Great and Small: The Complement System
Mathern, D. R., & Heeger, P. S. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06230614 · Cited by 290
The Pathogenesis of Chronic Renal Failure in Diabetic Nephropathy
Bohle, A., Wehrmann, M., Bogenschütz, O., Batz, C., Müller, G. A., & Müller, G. A. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80780-6 · Cited by 285
Yale, J. ‐., Bakris, G., Cariou, B., Nieto, J., David‐Neto, E., Yue, D., Wajs, E., Figueroa, K., Jiang, J., Law, G., et al. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12348 · Cited by 273
de Zeeuw, D., Bekker, P., Henkel, E., Hasslacher, C., Gouni-Berthold, I., Mehling, H., Potarca, A., Tesar, V., Heerspink, H. J. L., & Schall, T. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00261-2 · Cited by 273
Mechanisms of Endothelial Dysfunction, Injury, and Death
Pober, J. S., Min, W., & Bradley, J. R. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092155 · Cited by 272
Shurraw, S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.537 · Cited by 269
Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy
Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., & Kondo, M. (1991) · Kidney International · doi:10.1038/ki.1991.308 · Cited by 268
Mice deficient in α-actinin-4 have severe glomerular disease
Kos, C. H., Le, T. C., Sinha, S., Henderson, J. M., Kim, S. H., Sugimoto, H., Kalluri, R., Gerszten, R. E., & Pollak, M. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17988 · Cited by 268
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
Miao, F., Chen, Z., Genuth, S., Paterson, A., Zhang, L., Wu, X., Li, S. M., Cleary, P., Riggs, A., Harlan, D. M., et al. (2014) · Diabetes · doi:10.2337/db13-1251 · Cited by 253
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care
Narva, A. S., Norton, J. M., & Boulware, L. E. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07680715 · Cited by 251
MacKinnon, M., Shurraw, S., Akbari, A., Knoll, G. A., Jaffey, J., & Clark, H. D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.04.077 · Cited by 246
Induction and function of vascular adhesion protein-1 at sites of inflammation.
Salmi, M., Kalimo, K., & Jalkanen, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2255 · Cited by 245
Ko, Y.-A., Mohtat, D., Suzuki, M., Park, A. S. D., Izquierdo, M. C., Han, S. Y., Kang, H. M., Si, H., Hostetter, T., Pullman, J. M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r108 · Cited by 225
Role of the JAK/STAT signaling pathway in diabetic nephropathy
Marrero, M. B., Banes-Berceli, A. K., Stern, D. M., & Eaton, D. C. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00181.2005 · Cited by 219
Understanding the mechanisms of kidney fibrosis
Zhou, D., & Liu, Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.215 · Cited by 218
TNF receptors: signaling pathways and contribution to renal dysfunction
Al-Lamki, R. S., & Mayadas, T. N. (2015) · Kidney International · doi:10.1038/ki.2014.285 · Cited by 215
Budoff, M. J., Rader, D. J., Reilly, M. P., Mohler, E. R., Lash, J., Yang, W., Rosen, L., Glenn, M., Teal, V., & Feldman, H. I. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.04.024 · Cited by 215
Hawari, F. I., Rouhani, F. N., Cui, X., Yu, Z.-X., Buckley, C., Kaler, M., & Levine, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307981100 · Cited by 214
Lysophosphatidic acid as a lipid mediator with multiple biological actions
Aikawa, S., Hashimoto, T., Kano, K., & Aoki, J. (2015) · Journal of Biochemistry · doi:10.1093/jb/mvu077 · Cited by 214
PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
Takata, Y., Liu, J., Yin, F., Collins, A. R., Lyon, C. J., Lee, C.-H., Atkins, A. R., Downes, M., Barish, G. D., Evans, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708647105 · Cited by 210
Obesity, Smoking, and Physical Inactivity as Risk Factors for CKD: Are Men More Vulnerable?
Hallan, S., de Mutsert, R., Carlsen, S., Dekker, F. W., Aasarød, K., & Holmen, J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.11.027 · Cited by 208
Wnt signalling in kidney diseases: dual roles in renal injury and repair
Kawakami, T., Ren, S., & Duffield, J. S. (2013) · The Journal of Pathology · doi:10.1002/path.4121 · Cited by 205
Gembardt, F., Bartaun, C., Jarzebska, N., Mayoux, E., Todorov, V. T., Hohenstein, B., & Hugo, C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00145.2014 · Cited by 189
The role of B7 family molecules in hematologic malignancy
Greaves, P., & Gribben, J. G. (2013) · Blood · doi:10.1182/blood-2012-10-385591 · Cited by 187
The dark and bright side of atherosclerotic calcification
Pugliese, G., Iacobini, C., Fantauzzi, C. B., & Menini, S. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.011 · Cited by 184
Gorin, Y., Cavaglieri, R. C., Khazim, K., Lee, D.-Y., Bruno, F., Thakur, S., Fanti, P., Szyndralewiez, C., Barnes, J. L., Block, K., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00396.2014 · Cited by 183
(2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261315 · Cited by 180
Hodgin, J. B., Nair, V., Zhang, H., Randolph, A., Harris, R. C., Nelson, R. G., Weil, E. J., Cavalcoli, J. D., Patel, J. M., Brosius, F. C., et al. (2013) · Diabetes · doi:10.2337/db11-1667 · Cited by 178
Szczech, L. A., Stewart, R. C., Su, H.-L., DeLoskey, R. J., Astor, B. C., Fox, C. H., McCullough, P. A., & Vassalotti, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110535 · Cited by 172
Adiponectin Promotes Functional Recovery after Podocyte Ablation
Rutkowski, J. M., Wang, Z. V., Park, A. S. D., Zhang, J., Zhang, D., Hu, M. C., Moe, O. W., Susztak, K., & Scherer, P. E. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040414 · Cited by 172
Self-citationRole of dynamin, synaptojanin, and endophilin in podocyte foot processes
Soda, K., Balkin, D. M., Ferguson, S. M., Paradise, S., Milosevic, I., Giovedi, S., Volpicelli-Daley, L., Tian, X., Wu, Y., Ma, H., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65289 · Cited by 171
Kramann, R., Fleig, S. V., Schneider, R. K., Fabian, S. L., DiRocco, D. P., Maarouf, O., Wongboonsin, J., Ikeda, Y., Heckl, D., Chang, S. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74929 · Cited by 168
Castelino, F. V., Seiders, J., Bain, G., Brooks, S. F., King, C. D., Swaney, J. S., Lorrain, D. S., Chun, J., Luster, A. D., & Tager, A. M. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30262 · Cited by 168
Pirfenidone Is Renoprotective in Diabetic Kidney Disease
RamachandraRao, S. P., Zhu, Y., Ravasi, T., McGowan, T. A., Toh, I., Dunn, S. R., Okada, S., Shaw, M. A., & Sharma, K. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008090931 · Cited by 167
Landray, M. J., Emberson, J. R., Blackwell, L., Dasgupta, T., Zakeri, R., Morgan, M. D., Ferro, C. J., Vickery, S., Ayrton, P., Nair, D., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.07.016 · Cited by 165
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.303 · Cited by 164
Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance
Tian, X., Kim, J. J., Monkley, S. M., Gotoh, N., Nandez, R., Soda, K., Inoue, K., Balkin, D. M., Hassan, H., Son, S. H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69778 · Cited by 163
Inker, L. A., Heerspink, H. J. L., Mondal, H., Schmid, C. H., Tighiouart, H., Noubary, F., Coresh, J., Greene, T., & Levey, A. S. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.017 · Cited by 156
Advances in the pathogenesis and treatment of polycystic kidney disease
Patel, V., Chowdhury, R., & Igarashi, P. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283262ab0 · Cited by 151
Pyridorin in Type 2 Diabetic Nephropathy
Lewis, E. J., Greene, T., Spitalewiz, S., Blumenthal, S. S., Berl, T., Hunsicker, L. G., Pohl, M. A., Rohde, R. D., Raz, I., Yerushalmy, Y., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011030272 · Cited by 148
Al‐Lamki, R. S., Wang, J., Vandenabeele, P., Bradley, J. A., Thiru, S., Luo, D., Wang, M., Pober, J. S., & Bradley, J. R. (2005) · The FASEB Journal · doi:10.1096/fj.05-3841com · Cited by 146
Shao, Z., & Schwarz, H. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0510315 · Cited by 145
MicroRNA-21 in Glomerular Injury
Lai, J. Y., Luo, J., O'Connor, C. L., Jing, X., Nair, V., Ju, W., Randolph, A. E., Ben‐Dov, I. Z., Matar-Ujvary, R., Briskin, D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121274 · Cited by 145
Heerspink, H. J. L., Tighiouart, H., Sang, Y., Ballew, S. H., Mondal, H., Matsushita, K., Coresh, J., Levey, A. S., & Inker, L. A. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.018 · Cited by 143
Maahs, D. M., Caramori, M. L., Cherney, D. Z. I., Gałecki, A. T., Gao, C., Jalal, D. I., Perkins, B. A., Pop‐Busui, R., Rossing, P. R., Mauer, M. S., et al. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0381-0 · Cited by 142
The USRDS: What You Need to Know about What It Can and Can’t Tell Us about ESRD
Foley, R. N., & Collins, A. J. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06840712 · Cited by 142
Notch in the kidney: development and disease
Sirin, Y., & Suszták, K. (2011) · The Journal of Pathology · doi:10.1002/path.2967 · Cited by 142
Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings
Denker, M. G., Boyle, S., Anderson, A. H., Appel, L. J., Chen, J., Fink, J. C., Flack, J. M., Go, A. S., Horwitz, E. J., Hsu, C., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04260415 · Cited by 141
Niewczas, M. A., Ficociello, L., Johnson, A. C., Walker, W., Rosolowsky, E. T., Roshan, B., Warram, J. H., & Królewski, A. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03010608 · Cited by 139
Thacker, S. G., Berthier, C. C., Mattinzoli, D., Rastaldi, M. P., Kretzler, M., & Kaplan, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001782 · Cited by 137
Weiner, D. E., Carpenter, M. A., Levey, A. S., Ivanova, A., Cole, E. H., Hunsicker, L. G., Kasiske, B. L., Kim, S. J., Kusek, J. W., & Bostom, A. G. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04101.x · Cited by 136
Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies
Drechsler, C., Delgado, G., Wanner, C., Blouin, K., Pilz, S., Tomaschitz, A., Kleber, M. E., Dressel, A., Willmes, C., Krane, V., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010093 · Cited by 135
Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism
Han, S. H., Málaga-Diéguez, L., Chinga, F., Kang, H. M., Tao, J., Reidy, K. J., & Suszták, K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121181 · Cited by 134
A microscopic view on the renal endothelial glycocalyx
Dane, M. J. C., van den Berg, B. M., Lee, D. H., Boels, M. G. S., Tiemeier, G. L., Avramut, M. C., van Zonneveld, A. J., van der Vlag, J., Vink, H., & Rabelink, T. J. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00532.2014 · Cited by 132
Valproic Acid Attenuates Proteinuria and Kidney Injury
Beneden, K. V., Geers, C., Pauwels, M., Mannaerts, I., Verbeelen, D. L., van Grunsven, L. A., & Branden, C. V. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111196 · Cited by 132
Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes
Maalouf, R., Eid, A. A., Gorin, Y. C., Block, K. L., Escobar, G. P., Bailey, S. R., & Abboud, H. E. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2011 · Cited by 132
Role of Podocyte B7-1 in Diabetic Nephropathy
Fiorina, P., Vergani, A., Bassi, R., Niewczas, M. A., Altintas, M. M., Pezzolesi, M. G., D’Addio, F., Chin, M., Tezza, S., Nasr, M. B., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050518 · Cited by 132
Schiffer, M., Teng, B., Gu, C., Shchedrina, V. A., Kasaikina, M. V., Pham, V. A., Hanke, N., Rong, S., Gueler, F., Schröder, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3843 · Cited by 128
Gilbert, R. E., Huang, Q., Thai, K., Advani, S. L., Lee, K., Yuen, D. A., Connelly, K. A., & Advani, A. (2011) · Kidney International · doi:10.1038/ki.2011.39 · Cited by 126
Holtkamp, F. A., de Zeeuw, D., de Graeff, P. A., Laverman, G. D., Berl, T., Remuzzi, G., Packham, D., Lewis, J. B., Parving, H. ‐., & Heerspink, H. J. L. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr017 · Cited by 125
Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury
Awad, A. S., Kinsey, G. R., Khutsishvili, K., Gao, T., Bolton, W. K., & Okusa, M. D. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00332.2011 · Cited by 124
Tolvaptan plus Pasireotide Shows Enhanced Efficacy in a PKD1 Model
Hopp, K., Sieben, C. J., Wang, X., Ye, H., Harris, P. C., & Torres, V. E. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121312 · Cited by 124
Ting, R.-D., Keech, A. C., Drury, P. L., Donoghoe, M. W., Hedley, J., Jenkins, A. J., Davis, T. M. E., Lehto, S., Celermajer, D., Simes, R. J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1109 · Cited by 119
Korhonen, R., & Moilanen, E. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00375.x · Cited by 117
Lewis, E. J., Lewis, J. B., Greene, T., Hunsicker, L. G., Berl, T., Pohl, M. A., de Zeeuw, D., Heerspink, H. J. L., Rohde, R. D., Atkins, R. C., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.06.020 · Cited by 116
Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily
Flyvbjerg, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.266 · Cited by 115
Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice
Seok, S. J., Lee, E., Kim, G. T., Hyun, M., Lee, J.-H., Chen, S., Choi, R., Kim, H. M., Lee, E. Y., & Chung, C. H. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs555 · Cited by 113
Banes, A. K., Shaw, S., Jenkins, J., Redd, H., Amiri, F., Pollock, D. M., & Marrero, M. B. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00163.2003 · Cited by 112
Titan, S., Vieira, J. M., Dominguez, W. V., Moreira, S. R. S., Pereira, A. B., Barros, R. T., & Zatz, R. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.006 · Cited by 111
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Moriwaki, Y., Inokuchi, T., Yamamoto, A., Ka, T., Tsutsumi, Z., Takahashi, S., & Yamamoto, T. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0007-6 · Cited by 110
George, B., Verma, R., Soofi, A. A., Garg, P. K., Zhang, J., Park, T., Giardino, L., Ryzhova, L., Johnstone, D. B., Wong, H. N., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60070 · Cited by 108
Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease
Dessapt-Baradez, C., Woolf, A. S., White, K., Pan, J., Huang, J. L., Hayward, A. E., Price, K. L., Kolatsi‐Joannou, M., Locatelli, M., Diennet, M., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121218 · Cited by 108
Varga, J., & Pasche, B. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32830e48e8 · Cited by 107
Fufaa, G. D., Weil, E. J., Nelson, R. G., Hanson, R. L., Bonventre, J. V., Sabbisetti, V. S., Waikar, S. S., Mifflin, T. E., Zhang, X., Xie, D., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3389-3 · Cited by 107
Human Nephrosclerosis Triggers a Hypoxia-Related Glomerulopathy
Neusser, M. A., Lindenmeyer, M. T., Moll, A. G., Segerer, S., Edenhofer, I., Sen, K., Stiehl, D. P., Kretzler, M., Gröne, H., Schlöndorff, D., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090268 · Cited by 107
Ito, H., Abe, M., Mifune, M., Oshikiri, K., Antoku, S., Takeuchi, Y., & Togane, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027817 · Cited by 106
Current Status of Bicarbonate in CKD
Dobre, M. A., Rahman, M., & Hostetter, T. H. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014020205 · Cited by 103
Regression of Renal Vascular Fibrosis by Endothelin Receptor Antagonism
Boffa, J., Tharaux, P., Dussaule, J., & Chatziantoniou, C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.490 · Cited by 98
Dobre, M. A., Yang, W. P., Pan‐Hammarström, Q., Appel, L. J., Bellovich, K. A., Chen, J., Feldman, H. I., Fischer, M. J., Ham, L. L., Hostetter, T. H., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001599 · Cited by 98
Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection
Perico, N., Benigni, A., & Remuzzi, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2685 · Cited by 97
Basche, M., Gustafson, D. L., Holden, S. N., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2423 · Cited by 97
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury
Ma, J., Weisberg, A. D., Griffin, J. P., Vaughan, D. E., Fogo, A. B., & Brown, N. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000201 · Cited by 96
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice
Tesch, G. H., Ma, F. Y., Han, Y., Liles, J. T., Breckenridge, D. G., & Nikolic‐Paterson, D. J. (2015) · Diabetes · doi:10.2337/db15-0384 · Cited by 95
Decitre, M., Gleyzal, C., Raccurt, M., Peyrol, S., Aubert‐Foucher, E., Csiszár, K., & Sommer, P. (1998) · PubMed · Cited by 94
Yang, T., Liang, Y., Lin, Q., Liu, J., Luo, F., Li, X., Zhou, H., Zhuang, S., & Zhang, H. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24474 · Cited by 94
Abatacept in B7-1–Positive Proteinuric Kidney Disease
Greka, A., Weins, A., & Mundel, P. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1400502 · Cited by 92
APOL1 Null Alleles from a Rural Village in India Do Not Correlate with Glomerulosclerosis
Johnstone, D. B., SHEGOKAR, V. R., Nihalani, D., Rathore, Y. S., Mallik, L., Ashish, ZARE, V. R., Ikizler, H. O., POWAR, R. M., & Holzman, L. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051546 · Cited by 89
Zhao, Y., Conze, D. B., Hanover, J. A., & Ashwell, J. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609146200 · Cited by 87
Cited by
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis
Chung, K. W., Dhillon, P., Huang, S., Sheng, X., Shrestha, R., Qiu, C., Kaufman, B. A., Park, J., Pei, L., Baur, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.003 · Cited by 651
Self-citationSignaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
The fibrogenic niche in kidney fibrosis: components and mechanisms
Li, L., Fu, H., & Liu, Y. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00590-z · Cited by 440
Metadata
- Authors
- Breyer, M. D., & Susztak, K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-05-27
- Volume
- 15
- Issue
- 8
- Pages
- 568-588
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2401600644
- Cited by
- 272
- References
- 270
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.